ORIGINAL ARTICLE
One of the first studies that looked at fatigue in MS found that 43% of subjects identified "sleepiness" as part of the symptomatology of their fatigue. 2 It is known that some sleep disorders, in particular restless legs syndrome, are more prevalent in the MS population. [10] [11] [12] [13] A pilot study involving polysomnography of 12 MS patients suggested differences in sleep quality in patients with MS compared to controls, and a trend for increased sleepiness as measured objectively with the multiple sleep latency test.
14 Several small studies have found that treatment with modafinil, a wake-promoting agent, improved symptoms of MS fatigue, although in a larger randomized controlled trial there was no difference. [15] [16] [17] These studies did not use objective measures of alertness. Beyond these pharmaceutical studies, little research has been conducted into whether poor sleep and decreased alertness are major determinants of MS fatigue. It is important to clarify the contribution of sleep deprivation and poor alertness to MS fatigue as they may be more easily treated than other factors, such as disability.
In this study we set out to determine the relationship in MS between subjectively reported fatigue and objective sleepiness as evaluated by the psychomotor vigilance test (PVT). The PVT is a reaction-time task that has been validated in laboratory, clinical, and field studies investigating sleep, respiratory, and neurological disorders. [18] [19] [20] The PVT has been demonstrated to be highly sensitive to sleep loss and can easily be used in a clinical setting. We also assessed other factors, including demographics, disability, pain, mood, and sleep quality, to assess their relative contribution to psychomotor vigilance performance in this population.
METHODS
This was a prospective cohort study that enrolled 49 consecutive patients presenting to the MS clinics at two major Toronto teaching hospitals (St. Michael's Hospital and Sunnybrook Health Sciences Centre). Approval was obtained from the research ethics board at each hospital in advance of the study. Written informed consent was obtained from all participants. Exclusion criteria were self-report of visual impairment or any degree of hand or arm weakness.
Alertness was assessed using the PVT, which is a noninvasive reaction time task of ten minutes duration. It requires the subject to hold a small apparatus and press a button when a light signal appears on the screen of the device. The PVT measures reaction times over variable intervals of seconds between visual stimuli. Subjects are allowed a brief trial with the apparatus before the test begins to ensure that they understand the instructions. Key variables collected by the device include mean reaction time and number of lapses (response delays >500 msec). There is minimal learning effect on performance, as shown in other studies. 21 The primary outcome of interest was the mean reaction time (in milliseconds) on the PVT. Mean reaction times in the general population have been previously published, by gender and by age group. 19 The mean reaction time for a general population sample with the same gender and age distribution as the study population was estimated from these data. Self-reporting of fatigue was assessed using the Modified Fatigue Impact Scale (MFIS), an instrument that consists of 21 questions measuring social, physical, and cognitive aspects of fatigue. 22 Physical disability was assessed with the Expanded Disability Status Scale (EDSS) based on the patients' neurological examination findings, as documented by their own neurologist, on the day of the visit. Mood was graded with the Beck Depression Inventory fast screen (BDI-FS) for medically ill patients, and pain with the Medical Outcomes Study (MOS) Pain Effects Scale (PES); both are self-report questionnaires. The MFIS, EDSS, BDI-FS, and MOS PES are all validated instruments that are wellcharacterized in the MS population. [22] [23] [24] [25] Subjective sleepiness was evaluated using the Epworth Sleepiness Scale (ESS), which is a validated widely-used measure in the sleep literature. 26 Subjective sleep characteristics were assessed using a sleep questionnaire for common sleep habits. Variables of interest included duration of sleep, as well as restless legs, sleepdisordered breathing, and narcolepsy symptoms.
Restless legs was defined as often or always having a selfreported feeling of discomfort in the legs at night that improved with movement. Sleep-disordered breathing was suspected if the subject reported that s/he often or always snored at night. Narcolepsy symptoms were defined by self-reporting of sleepiness and at least two out of the following three symptoms: 1) muscular weakness associated with strong emotions; 2) sleep paralysis; and 3) hypnagogic or hypnapompic hallucinations.
Statistical analysis was carried out using the SPSS-16 program. We performed a stepwise multiple regression analysis to determine the best predictors of objective alertness, as measured by the PVT. Factors considered were gender, EDSS, BDI-FS, MFIS, PES, restlessness, duration of sleep, and ESS.
RESULTS
The average age of subjects was 43 (+11), and 65% were women ( Table 1 ). The median EDSS was 2.0 (range 0-7.5). Twenty-seven (55%) reported a high impact of fatigue on their lives. Five (10%) were on pharmaceutical treatment for fatigue with amantadine or modafinil. Twenty-eight (57%) were on disease modifying therapy and 13 (26.5%) were on an antidepressant.
The mean reaction time on the PVT was 315.0 (+65.1) with 90% of subjects demonstrating reaction times exceeding the 19 The mean number of lapses was 3.98 (+5.24) with 59% exceeding the mean (1.96) for an age-and sex-matched control (p=0.001). 19 The Figure, a scatter plot of MFIS score against PVT reaction time, demonstrates the correlation between reaction times and fatigue scores. The Pearson correlation coefficient was 0.38. The correlation coefficient (R) for the MFIS observed in our multiple regression model was similar at 0.365 (p<0.05) ( Table 2) .
Thirty percent endorsed sleepiness on the subjective ESS exceeding the normal threshold (10).
26 Eighteen (37%) described often or always having restlessness in their legs at night that improved with movement. Six (12%) endorsed snoring, suggesting sleep-disordered breathing. Seven (14%) subjects reported narcolepsy symptoms. These three groups of sleepdisordered patients each displayed prolonged average reaction times and higher MFIS scores compared to the rest of the MS patients, although these trends did not meet statistical significance.
In a stepwise regression model, fatigue (MFIS) showed the strongest correlation with PVT reaction time (p<0.05) ( Table 2 ). Other predictors of objective alertness were EDSS (p<0.01), duration of sleep (p=0.01), and female gender (p=0.01). Mood, pain, subjective sleepiness (high ESS scores), and restless legs were not associated with impaired objective alertness in this model.
DISCUSSION
This study demonstrated objective impairments in alertness using the psychomotor vigilance test, and a moderate correlation between alertness and subjectively reported fatigue in MS patients. The PVT has previously been shown to be sensitive to the benefits of bright light, naps, and caffeine in sleepy individuals and may be used to track treatment response. The PVT is a rapid test with little training required for either subject or administrator. Results do not vary with educational background. 21 It is associated with a minimal learning curve and has high test-retest reliability. 21 It offers an advantage over previously validated fatigue assessment tools in that it does not rely on self-report.
Furthermore, the PVT may offer unique benefits particularly for evaluating the impact of interventions on fatigue in an immediate way. The MFIS asks respondents to rate how much fatigue has contributed to each of a set of listed statements over the preceding four weeks. Other fatigue rating scales similarly elicit information about the impact of fatigue on activities over long periods of time. These rating scales need to designate a sufficiently long period that the subject's reported fatigue is not swayed by a few days of relative under-or over-exertion. However, their imposition of a longer timeframe may bias results as other extraneous factors become more important than the intervention in determining the subject's fatigue. For example, it may be difficult to prove that recent exertion, changes in temperature, or recently administered medications impact the MFIS, but the PVT allows for an immediate and focused outcome measure. In this study, fatigue scores, level of disability, longer sleeping times, and female gender were all associated with poor reaction time performance in MS patients; mood, pain, restless legs, and self-reported sleepiness were not. Mood has been characterized as a contributor to MS fatigue in many studies. [5] [6] [7] However, our findings suggest that mood may affect the perception of fatigue more than its cognitive correlates in MS. This hypothesis is supported by a recent study showing that MS patients' self-rankings on the Beck Depression Inventory Fast Screen were moderately correlated with rankings on the Fatigue Severity Scale, but not with cognitive results from formal neuropsychological testing. 27 Pain may also be more influential on perceptions of fatigue than on performance measures. However, the PVT is a simple task and it is possible that with a more complex, multi-step task these factors would be associated with a decline in performance. This could be an interesting direction for future research.
The finding of impaired alertness with more sleep was paradoxical. In a general population longer sleeping times correlate with better alertness. 21 The opposite finding here may reflect an underlying association between somnolence and a high lesion load, or somnolence resulting from poor quality sleep in MS. Assessing lesion burden was not within the scope of this study, but should be pursued in future investigations into MSrelated fatigue.
We found that restless leg and narcolepsy symptoms were prevalent in this MS population. The reason for this propensity may be related to lesion location, HLA-type, or other immunological mechanisms. 12, 21, 28 Sleep-disordered breathing tended to be associated with increased fatigue and poor alertness as it would in the general population. This finding did not meet statistical significance likely because of the relative rarity (n=6) of self-reported sleep-disordered breathing symptoms in this population. Restless legs symptoms (n=18) were common in this population, as has been reported for other groups of subjects with MS. [10] [11] [12] It is difficult to determine whether the lack of difference in reaction times between the subjects with restless leg symptoms and the other MS subjects was related to the subjective reporting of symptoms or to a true sparing of psychomotor vigilance. It would be worthwhile to explore psychomotor vigilance in MS subjects for whom sleep disturbances were objectively quantified with polysomnography.
CONCLUSION
The PVT reaction time offers considerable potential as an objective parameter for evaluating fatigue in MS patients. Reaction time performance was moderately correlated with the MFIS, a validated instrument for measuring fatigue in the MS population. The concept of fatigue, however, clearly includes more than impaired alertness. The PVT does not entirely capture features of depressed mood or pain, for example. Mood has been demonstrated in previous research to be correlated with MS fatigue, but did not significantly affect reaction times in this study. [4] [5] 7 The PVT can be influenced by demographic factors that have not been consistently linked to MS-related fatigue. For example, in other studies age has been shown to affect PVT performance, and in this study, gender was a significant contributor. 19 However, these observations also illustrate the drawback of traditional fatigue rating scales, which encompass several distinct parameters -short-term attention, exercise tolerance, sustained concentration capabilities -under the umbrella of fatigue. Perhaps it will be fruitful in the future to research MS fatigue by differentiating this entity into several, smaller, objectively defined components, including alertness. The PVT thus may prove very useful as a quantitative assessment tool of this important aspect of MS fatigue and help to identify and evaluate novel treatment targets.
